A standardized battery for use with adults suffering from Schizophrenia and related disorders
Overview
The MATRICS™ Consensus Cognitive Battery (MCCB™) is a standardized battery for use with adults suffering from Schizophrenia and related disorders. This is the only measure of cognitive performance that was developed under NIMH contract with participation from the U.S. Food and Drug Administration. It is recommended for all clinical trials of cognition-enhancing drugs for Schizophrenia.
Key Areas Measured
- Speed of Processing
- Attention/Vigilance
- Working Memory (verbal)
- Verbal Learning
- Visual Learning
- Working Memory (nonverbal)
- Social Cognition
- Reasoning and Problem Solving